Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. MU
5. META
6. FDX
7. IBM
8. PRIM
9. ACN
10. USO

Go back to Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
(NASDAQ: VERU) Delayed: 3.04 +0.08 (2.70%)
Previous Close $2.96    52 Week High $ 
Open $2.91    52 Week Low $ 
Day High $3.07    P/E N/A 
Day Low $2.91    EPS $ 
Volume 341,653